Table 4.
Distribution of neonatal outcome among mothers who gave birth by OVD in JUMC December 1, 2016–May 30, 2017.
| variable | Variable category | Neonatal outcome | Total | |
|---|---|---|---|---|
| Favorable outcome N (%) | Unfavorable outcome N (%) | |||
| Parity | I | 146(86.9) | 22(13.1) | 168(100.0) |
| II-IV | 51(96.2) | 2(3.8) | 53(100.0) | |
| ≥V | 13(61.9) | 8(38.1) | 21(100.0) | |
|
| ||||
| GA in weeks | pre-term | 12(85.7) | 2(14.3) | 14(100.0) |
| Term | 186(87.3) | 27(12.7) | 213(100.0) | |
| post term | 12(80.0) | 3(20) | 15(100.0) | |
|
| ||||
| ANC follow up | yes | 205(88.0) | 28(12.0) | 233(100.0) |
| No | 5(55.6) | 4(44.4) | 9(100.0) | |
|
| ||||
| Number of ANC follow up | one visit | 3(75.0) | 1(25.0) | 4(100.0) |
| two to three visit | 94(84.7) | 17(15.3) | 111(100.0) | |
| four and above visit | 108(91.5) | 10(8.5) | 118(100.0) | |
| no visit | 5(55.6) | 4(44.4) | 8(100.0) | |
|
| ||||
| Indication for OVD | NRFHRP | 115(84.6) | 21(15.4) | 136(100.0) |
| shortening SSOL | 44(91.7) | 4(8.3) | 48(100.0) | |
| prolonged SSOL | 51(87.9) | 7(12.1) | 58(100.0) | |
|
| ||||
| Type of OVD used | vacuum | 34(68.0) | 16(32.0) | 50(100.0) |
| forceps | 176(91.7) | 16(8.3) | 192(100.0) | |
|
| ||||
| Type of OVD applied | Low | 110(83.3) | 22(16.7) | 132(100.0) |
| outlet | 100(90.9) | 10(9.1) | 110(100.0) | |
|
| ||||
| Time of application | on arrival | 52(75.4) | 17(24.6) | 69(100.0) |
| followed | 158(91.7) | 15(8.3) | 173(100.0) | |
|
| ||||
| Status of liquor | clear | 163(94.8) | 9(5.2) | 172(100.0) |
| G1MSAF | 17(89.5) | 2(10.5) | 19(100.0) | |
| G2MSAF | 13(76.5) | 4(23.5) | 17(100.0) | |
| G3MSAF | 17(50.0) | 17(50.0) | 34(100.0) | |
|
| ||||
| weight of the newborn in grams | 1500-2499 | 13(92.9) | 1(7.1) | 14(100.0) |
| 2500-3999 | 192(86.9) | 29(13.1) | 221(100.0) | |
| >/=4000 | 5(71.4) | 2(28.6) | 7(100.0) | |